title: Commentary: The ALLHAT Study: implications for the management of resistant hypertension.
authors.affiliation: Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, Box 208017, New Haven, CT 06520-8017, USA.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Singer
authors.forename: John F
authors.initials: JF
authors.lastname: Setaro
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006331:Heart Diseases / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D016032:Randomized Controlled Trials as Topic
chemical_list: D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D000960:Hypolipidemic Agents; D008055:Lipids